MLoptic

MLoptic R&D / Revenue

The R&D to Revenue Ratio of MLoptic (688502.SS) as of Oct 27, 2026 is 11.88 %. In the previous year, R&D to Revenue Ratio was 13.98 % — a change of -15.03% (lower).

R&D / Revenue

11.88 %

YoY

-15.03%

Last updated:

R&D to Revenue Ratio of MLoptic is 2025 11.88 % . R&D to Revenue Ratio of MLoptic was 2024 13.98 % . It decreases by -15.03% lower compared to the previous year.

The MLoptic R&D / Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D / Revenue
Date
R&D / Revenue
Jan 1, 2019
9.94 CNY
Jan 1, 2020
10.79 CNY
Jan 1, 2021
13.71 CNY
Jan 1, 2022
12.40 CNY
Jan 1, 2023
14.66 CNY
Jan 1, 2024
13.98 CNY
Jan 1, 2025
11.88 CNY
The MLoptic R&D / Revenue history
YEARR&D / RevenueYoY
11.88 %-15.03%
13.98 %-4.66%
14.66 %+18.23%
12.40 %-9.58%
13.71 %+27.12%
10.79 %+8.47%
9.94 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

MLoptic Stock analysis

What does MLoptic do? MLOptic Corp. generates revenue through the research, development, design, manufacturing, and sales of precision optical devices, high-end optical lenses, and advanced optical systems. The company's main products include precision optics such as lenses, prisms, and plates, optical lenses like microscope objective lenses, machine vision lenses, imaging lenses, and monitoring lens series, and optical systems comprising semiconductor detection optical modules, medical detection optical system modules, biometric optical modules, augmented reality technology, virtual reality technology optical test modules, and optical detection equipment. These products are sold in both domestic and foreign markets to customers requiring high-precision optical solutions for industrial, medical, and technology applications. The firm targets industrial, medical, and technology sectors as key segments, with customers purchasing precision optics for manufacturing processes, optical lenses for machine vision and imaging applications, and optical systems for semiconductor and medical detection. The company's product portfolio serves diverse applications including semiconductor detection, medical diagnostics, biometric systems, and augmented and virtual reality technologies, ensuring steady demand across multiple high-tech industries. MLOptic Corp. focuses on delivering specialized optical components and systems that address specific technical challenges in advanced manufacturing and medical technology. By offering tailored solutions for semiconductor detection, medical diagnostics, and biometric identification, the company captures value in niche markets where precision and reliability are critical. This approach allows the company to maintain strong customer relationships and recurring revenue streams within its target sectors. MLoptic is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MLoptic stock

R&D to Revenue Ratio of MLoptic is 11.88 % in 2025.

R&D to Revenue Ratio of MLoptic changed from 13.98 % to 11.88 %, representing a -15.03% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of R&D to Revenue Ratio MLoptic since 2006 – with annual values, charts, and detailed analysis.

The R&D to Revenue ratio shows what percentage of revenue a company invests in research and development. Higher ratios indicate stronger focus on innovation.

A 'good' varies by industry and company stage. On Eulerpool, you can compare R&D to Revenue Ratio's MLoptic with sector peers and the industry average to assess whether it is attractive.

To evaluate R&D to Revenue Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for R&D to Revenue Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — MLoptic

All Key Metrics — MLoptic